1. Home
  2. NRXS

NRXS

Neuraxis Inc.

Logo Neuraxis Inc.

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Neuraxis Inc is a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology.

Founded: 2011 Country:
United States
United States
Employees: N/A City: CARMEL
Market Cap: 16.7M IPO Year: 2023
Target Price: N/A AVG Volume (30 days): 11.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.82 EPS Growth: N/A
52 Week Low/High: $1.80 - $6.93 Next Earning Date: 04-09-2024
Revenue: $2,541,673 Revenue Growth: 0.13%
Revenue Growth (this year): 84.15% Revenue Growth (next year): 140.41%

Share on Social Networks: